United States · FDA National Drug Code directory
DOXEPIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72603-920_77782f36-d120-4c3d-bebd-c8b0f4749d98
- Product NDC
- 72603-920
- Form
- TABLET
- Composition / generic term
- DOXEPIN
- Labeler
- NorthStar Rx LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260801
- Source listing expiry
- 20271231
Source-listed ingredients
- DOXEPIN HYDROCHLORIDE — 6 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (72603-920-01) · 72603-920-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →